You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment

Article metrics

Article menu
XML
Basic tumor immunology
Original research
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment

 

Online download statistics by month:

Online download statistics by month: February 2021 to September 2025

AbstractFullPdf
Feb 2021963963477
Mar 2021450450268
Apr 2021238238124
May 202117717788
Jun 2021222221142
Jul 202121121184
Aug 202118718788
Sep 2021160160135
Oct 2021139139117
Nov 2021186185134
Dec 2021169172113
Jan 2022161195134
Feb 2022125141107
Mar 2022117123108
Apr 2022130138136
May 2022499508130
Jun 202215917195
Jul 2022165168113
Aug 202214815094
Sep 2022135137109
Oct 2022180186124
Nov 202218518785
Dec 202212212664
Jan 202310610855
Feb 202315515772
Mar 202314314588
Apr 2023111112100
May 202310210272
Jun 202312712970
Jul 2023909078
Aug 202311411479
Sep 202313713780
Oct 202310010157
Nov 202316516774
Dec 202312913084
Jan 2024133135102
Feb 202413513996
Mar 2024174175209
Apr 2024164164128
May 2024174175119
Jun 202413413572
Jul 2024182187103
Aug 202416016196
Sep 202412612683
Oct 2024153154105
Nov 2024202203128
Dec 2024234238112
Jan 2025163164116
Feb 2025307307162
Mar 2025218218150
Apr 2025204204151
May 2025198200140
Jun 2025979868
Jul 2025225
Sep 2025110
Total9868100116123